The Scientist

» neuron and immunology

Most Recent

image: Sex Differences in Pain Pathway

Sex Differences in Pain Pathway

By | June 29, 2015

Male and female mice utilize different immune cells to process pain, a study shows.

1 Comment

image: Neutralizing HIV

Neutralizing HIV

By | June 18, 2015

Engineered immunogens based on conserved patches of the virus’s envelope protein point to new strategies for vaccine design.

0 Comments

image: Brain Drain

Brain Drain

By | June 1, 2015

The brain contains lymphatic vessels similar to those found elsewhere in the body, a mouse study shows.

3 Comments

image: New Immunity

New Immunity

By | June 1, 2015

A scaffolding protein forms the hub of a newly identified immune pathway in plants.

0 Comments

image: Gene Linked to Pain Insensitivity

Gene Linked to Pain Insensitivity

By | May 27, 2015

People with a congenital disorder that makes them unable to feel pain have mutations in a histone-modifying gene. 

0 Comments

image: Measles Vax’s Off-Target Effects

Measles Vax’s Off-Target Effects

By | May 11, 2015

Researchers find evidence that measles vaccines reduced deaths from other infectious diseases due to “immune amnesia.”

2 Comments

image: Outsmarting HIV

Outsmarting HIV

By | May 4, 2015

Small molecules that mimic the T-cell surface receptor CD4 could expose the virus to antibody-based immune responses.

0 Comments

image: Filippos Porichis: Immunoregulator

Filippos Porichis: Immunoregulator

By | May 1, 2015

Principal Investigator, Ragon Institute of MGH, MIT, and Harvard. Age: 33

0 Comments

image: Llamas as Lab Rats

Llamas as Lab Rats

By | May 1, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

0 Comments

image: Looking for Latent HIV

Looking for Latent HIV

By | May 1, 2015

Sequencing HIV integration sites suggests that clonally expanded T-cell populations may not be the main source of latent virus.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech